INVA logo

Innoviva (INVA) Selling, General & Administrative Expenses

Annual SGA

$115.69 M
+$17.46 M+17.77%

December 31, 2024

Summary

Performance

1-Year Change

+17.77%

3-Year Change

+614.71%

5-Year Change

+689.37%

15-Year Change

+258.64%

INVA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.39%
INVA annual SGA is higher than 74.39% of companies in Healthcare sector

High & Low

All-time High

$115.69 M
INVA annual SGA is currently at an all-time high

3-Year Low

$16.19 M
INVA annual SGA is currently +614.71% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
INVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
INVA next annual earnings announcement has not yet been scheduled

OtherINVAexpensesmetrics:

Annual Total Expenses

$191.84 M
INVA annual total expenses is $191.84 million

Annual Operating Expenses

$155.25 M
INVA annual total operating expenses is $155.25 million

Annual Cost Of Goods Sold

$36.60 M
INVA annual cost of goods sold is $36.60 million

Annual Interest Expense

$22.21 M
INVA annual interest expense is $22.21 million

Quarterly SGA

$31.33 M
+$5.11 M+19.48%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+906.3%

5-Year Change

+1122.24%

INVA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.14%
INVA quarterly SGA is higher than 74.14% of companies in Healthcare sector

High & Low

All-time High

$31.33 M
INVA quarterly SGA is currently at an all-time high

3-Year Low

$3.11 M
INVA quarterly SGA is currently +906.30% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
INVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
INVA next earnings announcement has not yet been scheduled

OtherINVAexpensesmetrics:

Quarterly Total Expenses

$48.67 M
INVA quarterly total expenses is $48.67 million

Quarterly Operating Expenses

$41.50 M
INVA quarterly total operating expenses is $41.50 million

Quarterly Cost Of Goods Sold

$7.17 M
INVA quarterly cost of goods sold is $7.17 million

Quarterly Interest Expense

$4.75 M
INVA quarterly interest expense is $4.75 million

TTM SGA

-$35.92 M
+$23.39 M+39.44%

December 31, 2024

Summary

Performance

3-Month Change

-131.05%

1-Year Change

-131.05%

3-Year Change

-321.94%

5-Year Change

-352.92%

INVA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.96%
INVA TTM SGA is higher than 85.96% of companies in Healthcare sector

High & Low

All-time High

-$35.92 M
INVA TTM SGA is currently at an all-time high

3-Year Low

-$2.09 B

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
INVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
INVA next earnings announcement has not yet been scheduled

OtherINVAexpensesmetrics:

Annual Total Expenses

$191.84 M
INVA annual total expenses is $191.84 million

Annual Operating Expenses

$155.25 M
INVA annual total operating expenses is $155.25 million

TTM Cost Of Goods Sold

$36.60 M
INVA TTM cost of goods sold is $36.60 million

TTM Interest Expense

$22.21 M
INVA TTM interest expense is $22.21 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$115.69 M
INVA annual SGA is $115.69 million

Annual Operating Expenses

$155.25 M
INVA annual total operating expenses is $155.25 million

Annual Cost Of Goods Sold

$36.60 M
INVA annual cost of goods sold is $36.60 million

INVA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+17.8%0.0%-131.1%
3 y3 years+614.7%+906.3%-321.9%
5 y5 years+689.4%+1122.2%-352.9%

INVA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+614.7%at high+906.3%at high+98.3%
5 y5-yearat high+733.3%at high+1243.3%at high+99.1%
alltimeall timeat high+957.8%at high+5364.9%at high+99.5%

Innoviva Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$115.69 M(+17.8%)
$31.33 M(+19.5%)
$115.69 M(+4.5%)
Sep 2024
-
$26.22 M(-5.5%)
$110.68 M(-2.1%)
Jun 2024
-
$27.74 M(-8.8%)
$113.10 M(+3.9%)
Mar 2024
-
$30.41 M(+15.5%)
$108.90 M(+10.9%)
Dec 2023
$98.23 M(+54.6%)
$26.32 M(-8.1%)
$98.23 M(+9.9%)
Sep 2023
-
$28.64 M(+21.6%)
$89.37 M(+0.9%)
Jun 2023
-
$23.54 M(+19.3%)
$88.54 M(+15.3%)
Mar 2023
-
$19.73 M(+13.1%)
$76.78 M(+20.8%)
Dec 2022
$63.54 M(+292.5%)
$17.45 M(-37.2%)
$63.54 M(+29.2%)
Sep 2022
-
$27.81 M(+136.0%)
$49.20 M(+102.9%)
Jun 2022
-
$11.78 M(+81.5%)
$24.25 M(+45.3%)
Mar 2022
-
$6.49 M(+108.5%)
$16.69 M(+3.1%)
Dec 2021
$16.19 M(+16.6%)
$3.11 M(+8.8%)
$16.19 M(-12.7%)
Sep 2021
-
$2.86 M(-32.4%)
$18.54 M(-2.1%)
Jun 2021
-
$4.23 M(-29.4%)
$18.94 M(+9.4%)
Mar 2021
-
$5.99 M(+9.4%)
$17.31 M(+24.7%)
Dec 2020
$13.88 M(-5.3%)
$5.47 M(+68.1%)
$13.88 M(+29.2%)
Sep 2020
-
$3.25 M(+25.3%)
$10.74 M(-13.7%)
Jun 2020
-
$2.60 M(+1.3%)
$12.45 M(-12.3%)
Mar 2020
-
$2.56 M(+9.9%)
$14.20 M(-3.1%)
Dec 2019
$14.66 M(-35.6%)
$2.33 M(-53.0%)
$14.66 M(-2.0%)
Sep 2019
-
$4.96 M(+14.1%)
$14.96 M(+6.7%)
Jun 2019
-
$4.35 M(+44.2%)
$14.02 M(-0.5%)
Mar 2019
-
$3.02 M(+14.3%)
$14.08 M(-38.1%)
Dec 2018
$22.75 M(-29.5%)
$2.64 M(-34.4%)
$22.75 M(-0.6%)
Sep 2018
-
$4.02 M(-8.9%)
$22.88 M(-15.8%)
Jun 2018
-
$4.41 M(-62.3%)
$27.18 M(-18.0%)
Mar 2018
-
$11.69 M(+322.0%)
$33.15 M(+2.8%)
Dec 2017
$32.26 M(+39.1%)
$2.77 M(-66.7%)
$32.26 M(-8.1%)
Sep 2017
-
$8.31 M(-20.0%)
$35.09 M(+10.1%)
Jun 2017
-
$10.38 M(-3.8%)
$31.89 M(+15.0%)
Mar 2017
-
$10.79 M(+92.6%)
$27.73 M(+19.6%)
Dec 2016
$23.19 M(+17.4%)
$5.61 M(+9.8%)
$23.19 M(+3.5%)
Sep 2016
-
$5.11 M(-18.0%)
$22.40 M(+2.4%)
Jun 2016
-
$6.22 M(-0.4%)
$21.88 M(+6.4%)
Mar 2016
-
$6.25 M(+29.7%)
$20.56 M(+4.1%)
Dec 2015
$19.75 M(-43.4%)
$4.82 M(+5.2%)
$19.75 M(-7.3%)
Sep 2015
-
$4.58 M(-6.7%)
$21.30 M(-16.0%)
Jun 2015
-
$4.91 M(-9.7%)
$25.35 M(-12.7%)
Mar 2015
-
$5.44 M(-14.7%)
$29.05 M(-16.7%)
Dec 2014
$34.86 M
$6.37 M(-26.2%)
$34.86 M(-0.1%)
Sep 2014
-
$8.63 M(+0.3%)
$34.90 M(+8.1%)
Jun 2014
-
$8.60 M(-23.6%)
$32.28 M(+9.5%)
DateAnnualQuarterlyTTM
Mar 2014
-
$11.26 M(+75.7%)
$29.49 M(+11.1%)
Dec 2013
$24.29 M(+7.4%)
$6.41 M(+6.5%)
$26.55 M(+35.8%)
Sep 2013
-
$6.02 M(+3.6%)
$19.55 M(-8.2%)
Jun 2013
-
$5.81 M(-30.2%)
$21.28 M(-7.7%)
Mar 2013
-
$8.31 M(-1497.5%)
$23.06 M(+2.0%)
Dec 2012
$22.61 M(-26.3%)
-$595.00 K(-107.7%)
$22.61 M(-28.6%)
Sep 2012
-
$7.75 M(+2.2%)
$31.67 M(-0.1%)
Jun 2012
-
$7.59 M(-3.4%)
$31.71 M(+1.1%)
Mar 2012
-
$7.86 M(-7.2%)
$31.37 M(+2.2%)
Dec 2011
$30.68 M(+11.7%)
$8.47 M(+8.6%)
$30.68 M(+3.6%)
Sep 2011
-
$7.80 M(+7.6%)
$29.61 M(+4.2%)
Jun 2011
-
$7.25 M(+1.1%)
$28.43 M(+0.9%)
Mar 2011
-
$7.17 M(-3.1%)
$28.17 M(+2.5%)
Dec 2010
$27.48 M(+1.5%)
$7.40 M(+11.9%)
$27.48 M(+4.7%)
Sep 2010
-
$6.61 M(-5.4%)
$26.23 M(-1.7%)
Jun 2010
-
$6.99 M(+8.0%)
$26.68 M(+0.7%)
Mar 2010
-
$6.48 M(+5.2%)
$26.49 M(-2.1%)
Dec 2009
$27.07 M(-6.2%)
$6.16 M(-12.8%)
$27.07 M(+0.8%)
Sep 2009
-
$7.06 M(+3.9%)
$26.85 M(+2.2%)
Jun 2009
-
$6.80 M(-3.6%)
$26.29 M(-1.7%)
Mar 2009
-
$7.05 M(+18.6%)
$26.75 M(-7.3%)
Dec 2008
$28.86 M(-18.3%)
$5.95 M(-8.5%)
$28.86 M(-8.3%)
Sep 2008
-
$6.49 M(-10.5%)
$31.46 M(-5.9%)
Jun 2008
-
$7.26 M(-20.8%)
$33.42 M(-6.3%)
Mar 2008
-
$9.17 M(+7.3%)
$35.68 M(+1.0%)
Dec 2007
$35.31 M(+9.7%)
$8.54 M(+0.9%)
$35.31 M(+1.1%)
Sep 2007
-
$8.46 M(-11.0%)
$34.92 M(+1.7%)
Jun 2007
-
$9.51 M(+8.1%)
$34.33 M(+1.8%)
Mar 2007
-
$8.80 M(+7.9%)
$33.72 M(+4.7%)
Dec 2006
$32.19 M(+19.5%)
$8.15 M(+3.6%)
$32.19 M(+6.2%)
Sep 2006
-
$7.87 M(-11.6%)
$30.31 M(+6.1%)
Jun 2006
-
$8.90 M(+22.3%)
$28.57 M(+6.3%)
Mar 2006
-
$7.27 M(+16.1%)
$26.89 M(+6.5%)
Dec 2005
$26.93 M(-5.0%)
$6.27 M(+2.2%)
$25.25 M(+0.2%)
Sep 2005
-
$6.13 M(-15.0%)
$25.20 M(+2.4%)
Jun 2005
-
$7.21 M(+28.0%)
$24.62 M(-18.8%)
Mar 2005
-
$5.64 M(-9.4%)
$30.30 M(+22.8%)
Dec 2004
$28.34 M(+97.3%)
$6.22 M(+12.1%)
$24.67 M(+33.7%)
Sep 2004
-
$5.55 M(-57.0%)
$18.45 M(+43.0%)
Jun 2004
-
$12.90 M
$12.90 M
Dec 2003
$14.37 M(-14.3%)
-
-
Dec 2002
$16.76 M(+53.2%)
-
-
Dec 2000
$10.94 M
-
-

FAQ

  • What is Innoviva annual SGA?
  • What is the all time high annual SGA for Innoviva?
  • What is Innoviva annual SGA year-on-year change?
  • What is Innoviva quarterly SGA?
  • What is the all time high quarterly SGA for Innoviva?
  • What is Innoviva quarterly SGA year-on-year change?
  • What is Innoviva TTM SGA?
  • What is the all time high TTM SGA for Innoviva?
  • What is Innoviva TTM SGA year-on-year change?

What is Innoviva annual SGA?

The current annual SGA of INVA is $115.69 M

What is the all time high annual SGA for Innoviva?

Innoviva all-time high annual SGA is $115.69 M

What is Innoviva annual SGA year-on-year change?

Over the past year, INVA annual SGA has changed by +$17.46 M (+17.77%)

What is Innoviva quarterly SGA?

The current quarterly SGA of INVA is $31.33 M

What is the all time high quarterly SGA for Innoviva?

Innoviva all-time high quarterly SGA is $31.33 M

What is Innoviva quarterly SGA year-on-year change?

Over the past year, INVA quarterly SGA has changed by $0.00 (0.00%)

What is Innoviva TTM SGA?

The current TTM SGA of INVA is -$35.92 M

What is the all time high TTM SGA for Innoviva?

Innoviva all-time high TTM SGA is -$35.92 M

What is Innoviva TTM SGA year-on-year change?

Over the past year, INVA TTM SGA has changed by -$151.62 M (-131.05%)